Meyer Paula S, Kammann Marc T, Meyer Carsten H
Macular Center Davos, Switzerland.
Am J Ophthalmol Case Rep. 2021 Jul 10;23:101154. doi: 10.1016/j.ajoc.2021.101154. eCollection 2021 Sep.
To present the surgical treatment of a full thickness macular hole (MH) caused by a vitreomacular traction (VMT) on top of an adjacent subfoveal pigment epithelial detachment (PED) in age-related macular degeneration (AMD).
A 77-year-old female with a subfoveal PED receiving consecutive intravitreal injections noticed a sudden decreased visual acuity (VA) due to the development an occult MH in her right eye after 19 repeated intravitreal anti vascular endothelial growth factor (VEGF)-injections. Her initial VA declined from 20/50 to 20/400. The firm VMT induced a rupture of the multi-layered retina and may progress to an RPE-tear or possible to a subretinal haemorrhage. We discussed with the patient the risks of the natural progression and explained possible treatment options: We continued her anti-VEGF combined with air bubble injections to induce a posterior vitreous detachment, to stabilise the retinal architecture, reduce the subretinal fluid and avoid possible intraoperative bleeding. As injections did release the VMT, vitrectomy released the posterior vitreous from the optic nerve and trimmed it towards the central retina. Peeling with brilliant blue removed the internal limiting membrane without any signs of bleeding, rupture of the PED or enlargement of the MH, prior to the installation of 10% SF6 gas. The postoperative optical coherence tomography (OCT) on day 5 confirmed a closed MH, while the size, shape and pattern of the PED remained unchanged. Her VA increased from 20/400 to 20/50 (equal to her previous VA prior to the MH-formation). To avoid a potential progression of the PED, we maintained her retreatment intervals at 5 weeks for the next 6 months. A literature review presents similar intraoperative approaches and postoperative outcomes in 8 out of the 9 published cases.
VMT can induce an occult MH on top of a PED, causing a significant loss of vision. When gas injections are not successful, surgery may release the traction, restore the retinal architecture, and significantly improve and maintain the VA over a documented long-term observation. The epiretinal procedure should be assisted under regular anti-VEGF injections to maintain the subretinal architecture.
介绍对年龄相关性黄斑变性(AMD)中相邻黄斑下色素上皮脱离(PED)上方的玻璃体黄斑牵引(VMT)所致的全层黄斑裂孔(MH)的手术治疗。
一名患有黄斑下PED的77岁女性在连续接受玻璃体内注射治疗期间,在右眼19次重复玻璃体内注射抗血管内皮生长因子(VEGF)后,因隐匿性MH的形成而突然出现视力下降(VA)。其初始视力从20/50降至20/400。牢固的VMT导致多层视网膜破裂,并可能进展为视网膜色素上皮(RPE)撕裂或可能出现视网膜下出血。我们与患者讨论了自然病程的风险,并解释了可能的治疗方案:我们继续为她进行抗VEGF治疗并联合气泡注射以诱导玻璃体后脱离,稳定视网膜结构,减少视网膜下液并避免术中可能出现的出血。由于注射确实解除了VMT,玻璃体切除术将玻璃体后皮质从视神经处分离并向中央视网膜修剪。在注入10%的六氟化硫(SF6)气体之前,用亮蓝进行视网膜内界膜剥除,未出现任何出血迹象、PED破裂或MH扩大。术后第5天的光学相干断层扫描(OCT)证实MH闭合,而PED的大小、形状和形态保持不变。她的视力从20/400提高到20/50(与MH形成前的视力相同)。为避免PED可能的进展,我们在接下来的6个月中将她的再次治疗间隔维持在5周。文献综述显示,在已发表的9例病例中有8例具有类似的术中方法和术后结果。
VMT可在PED上方诱发隐匿性MH,导致明显的视力丧失。当气体注射不成功时,手术可解除牵引,恢复视网膜结构,并在长期记录观察中显著改善和维持视力。视网膜表面手术应在定期抗VEGF注射的辅助下进行,以维持视网膜下结构。